{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:06:30Z","timestamp":1792181190407,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cmi.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T02:27:06Z","timestamp":1686191226000},"page":"1267-1271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Management of uncomplicated urinary tract infection in the post-antibiotic era: select non-antibiotic approaches"],"prefix":"10.1016","volume":"29","author":[{"given":"Shawna","family":"McCallin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.06.001_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/318850","article-title":"Urinary tract infections: disease panorama and challenges","volume":"183","author":"Stamm","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2023.06.001_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2023.06.001_bib3","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.cmi.2023.06.001_bib4","first-page":"1","article-title":"Ambulatory medical care utilization estimates for 2007","volume":"13","author":"Schappert","year":"2011","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.cmi.2023.06.001_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"Foxman","year":"2014","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.cmi.2023.06.001_bib6","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.06.001_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/clind\/15.6.1041","article-title":"Guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection: additional considerations","volume":"15","author":"Kunin","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.06.001_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s15010-007-6180-2","article-title":"Community-onset urinary tract infections: a population-based assessment","volume":"35","author":"Laupland","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2023.06.001_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/ijpvm.IJPVM_419_17","article-title":"Pattern of antibacterial resistance in urinary tract infections: a systematic review and meta-analysis","volume":"10","author":"Mortazavi-Tabatabaei","year":"2019","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.cmi.2023.06.001_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAI-0014-2019","article-title":"Reaching the end of the line: urinary tract infections","volume":"7","author":"Tamadonfar","year":"2019","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cmi.2023.06.001_bib11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrurol.2015.199","article-title":"The emerging threat of multidrug-resistant Gram-negative bacteria in urology","volume":"12","author":"Zowawi","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.cmi.2023.06.001_bib12","first-page":"22","article-title":"EAU guidelines on urological infections","volume":"18","author":"Bonkat","year":"2019","journal-title":"Eur Assoc Urol"},{"key":"10.1016\/j.cmi.2023.06.001_bib13","first-page":"282","article-title":"Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline","volume":"202","author":"Anger","year":"2019","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.cmi.2023.06.001_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13756-019-0656-6","article-title":"Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study","volume":"8","author":"Gomila","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2023.06.001_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/02813432.2018.1499602","article-title":"Predictors of symptom duration and bacteriuria in uncomplicated urinary tract infection","volume":"36","author":"Bollestad","year":"2018","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.cmi.2023.06.001_bib16","doi-asserted-by":"crossref","first-page":"e830","DOI":"10.3399\/bjgp17X693641","article-title":"Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study","volume":"67","author":"Butler","year":"2017","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cmi.2023.06.001_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2296-12-111","article-title":"Does clinical examination aid in the diagnosis of urinary tract infections in women? A systematic review and meta-analysis","volume":"12","author":"Medina-Bombardo","year":"2011","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.cmi.2023.06.001_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1742-1241.2012.02906.x","article-title":"Symptom-based diagnosis of urinary tract infection in women: are we over-prescribing antibiotics?","volume":"66","author":"Mishra","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.cmi.2023.06.001_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035074","article-title":"Predicting the use of antibiotics after initial symptomatic treatment of an uncomplicated urinary tract infection: analyses performed after a randomised controlled trial","volume":"10","author":"Vik","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2023.06.001_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/fampra\/20.1.1","article-title":"Clinical management of urinary tract infection in women: a prospective cohort study","volume":"20","author":"Fahey","year":"2003","journal-title":"Fam Pract"},{"key":"10.1016\/j.cmi.2023.06.001_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/02813432.2021.2004721","article-title":"Prescribing antibiotics: the use of diagnostic tests in general practice. A register-based study","volume":"39","author":"Sydenham","year":"2021","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.cmi.2023.06.001_bib22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/MOU.0000000000000821","article-title":"Nonantibiotic treatments for urinary cystitis: an update","volume":"30","author":"Barea","year":"2020","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.cmi.2023.06.001_bib23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00404-019-05256-z","article-title":"Prevention and treatment of uncomplicated lower urinary tract infections in the era of increasing antimicrobial resistance-non-antibiotic approaches: a systemic review","volume":"300","author":"Wawrysiuk","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.cmi.2023.06.001_bib24","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.3390\/molecules25235593","article-title":"Promising roles of alternative medicine and plant-based nanotechnology as remedies for urinary tract infections","volume":"25","author":"Chandra","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cmi.2023.06.001_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/1440-1681.13092","article-title":"Therapeutic potential of medicinal plants for the management of urinary tract infection: a systematic review","volume":"46","author":"Shaheen","year":"2019","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.cmi.2023.06.001_bib26","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/archinternmed.2012.3004","article-title":"Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials","volume":"172","author":"Wang","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2023.06.001_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256992","article-title":"Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: a systematic review and meta-analysis with trial sequential analysis","volume":"16","author":"Xia","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2023.06.001_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/antibiotics10010012","article-title":"Cranberry extract for symptoms of acute, uncomplicated urinary tract infection: a systematic review","volume":"10","author":"Gbinigie","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2023.06.001_bib29","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.cmi.2021.05.032","article-title":"Herbal treatment with uva ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: a randomized controlled trial","volume":"27","author":"Gagyor","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.06.001_bib30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cmi.2019.01.011","article-title":"Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial","volume":"25","author":"Moore","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.06.001_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000493368","volume":"101","author":"Wagenlehner","year":"2018","journal-title":"Urol Int"},{"key":"10.1016\/j.cmi.2023.06.001_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/antibiotics10060685","article-title":"Treatment of urinary tract infections with canephron((R)) in Germany: a retrospective database analysis","volume":"10","author":"Holler","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2023.06.001_bib33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/antibiotics8040256","article-title":"Effect of a herbal therapy on clinical symptoms of acute lower uncomplicated urinary tract infections in women: secondary analysis from a randomized controlled trial","volume":"8","author":"Vahlensieck","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2023.06.001_bib34","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/antibiotics9120929","article-title":"Validation of the American English acute cystitis symptom score","volume":"9","author":"Alidjanov","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2023.06.001_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12941-021-00433-y","article-title":"Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review","volume":"20","author":"Chegini","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.cmi.2023.06.001_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","article-title":"Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial","volume":"21","author":"Leitner","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.06.001_bib37","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3389\/fmicb.2018.01832","article-title":"Adapted bacteriophages for treating urinary tract infections","volume":"9","author":"Ujmajuridze","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2023.06.001_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.06.001_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cmi.2023.06.001_bib40","doi-asserted-by":"crossref","first-page":"ofaa389","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States","volume":"7","author":"Aslam","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2023.06.001_bib41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/22221751.2020.1747950","article-title":"Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae","volume":"9","author":"Bao","year":"2020","journal-title":"Emerg Microbe. Infect"},{"key":"10.1016\/j.cmi.2023.06.001_bib42","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/cid\/ciz782","article-title":"Eradication of a multidrug-resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom made, lytic bacteriophage preparation","volume":"70","author":"Corbellino","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.06.001_bib43","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/jmm.0.029744-0","article-title":"Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection","volume":"60","author":"Khawaldeh","year":"2011","journal-title":"J\u00a0Med Microbiol"},{"issue":"1","key":"10.1016\/j.cmi.2023.06.001_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01281-19","article-title":"A Dutch case report of successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant patient","volume":"64","author":"Kuipers","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2023.06.001_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13391","article-title":"Treatment of recurrent urinary tract infections in a 60-year-old kidney transplant recipient. The use of phage therapy","volume":"23","author":"Rostkowska","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.cmi.2023.06.001_bib46","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3390\/v13101901","article-title":"Phage therapy experience at the eliava phage therapy center: three cases of bacterial persistence","volume":"13","author":"Zaldastanishvili","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.cmi.2023.06.001_bib47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/v10020064","article-title":"The magistral phage","volume":"10","author":"Pirnay","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.cmi.2023.06.001_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00345-013-1091-6","article-title":"D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial","volume":"32","author":"Kranjcec","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.cmi.2023.06.001_bib49","first-page":"208","article-title":"Oral D-mannose in recurrent urinary tract infections in women: a pilot study","volume":"7","author":"Porru","year":"2014","journal-title":"J\u00a0Clin Urol"},{"key":"10.1016\/j.cmi.2023.06.001_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037128","article-title":"D-MannosE to prevent recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial","volume":"11","author":"Franssen","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2023.06.001_bib51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1741-7015-8-30","article-title":"Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? \u2014 Results of a randomized controlled pilot trial","volume":"8","author":"Bleidorn","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.cmi.2023.06.001_bib52","doi-asserted-by":"crossref","first-page":"h6544","DOI":"10.1136\/bmj.h6544","article-title":"Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial","volume":"351","author":"Gagyor","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.06.001_bib53","doi-asserted-by":"crossref","first-page":"j4784","DOI":"10.1136\/bmj.j4784","article-title":"Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial","volume":"359","author":"Kronenberg","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.06.001_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002569","article-title":"Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women\u2014a double-blind, randomized non-inferiority trial","volume":"15","author":"Vik","year":"2018","journal-title":"PLOS Med"},{"key":"10.1016\/j.cmi.2023.06.001_bib55","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.cmi.2022.06.017","article-title":"Reducing antibiotic use in uncomplicated urinary tract infections in adult women: a systematic review and individual participant data meta-analysis","volume":"28","author":"Kaussner","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2023.06.001_bib56","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1001\/jama.287.20.2701","article-title":"Does this woman have an acute uncomplicated urinary tract infection?","volume":"287","author":"Bent","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2023.06.001_bib57","first-page":"729","article-title":"Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","author":"Christiaens","year":"2002","journal-title":"Br J Gen Pract"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23002768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23002768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:35:52Z","timestamp":1761118552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23002768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1198743X23002768"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.06.001","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of uncomplicated urinary tract infection in the post-antibiotic era: select non-antibiotic approaches","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}